Skip to main content

FDA recall, , Low risk

Datascope Battery Charging Station

The Battery Charging Station has a protruding screw that prevents proper charging of certain batteries.

What happened

Datascope Corp., of Mahwah, New Jersey, recalled the Battery Charging Station because a protruding screw in the left battery bay limits full insertion of certain batteries and prevents proper charging. The station is an optional dual-bay charger used to charge the Cardiosave IABP Lithium-Ion batteries when they are not being used to operate the IABP. The recall began February 6, 2026, and was added to the FDA's Enforcement Report on March 19, 2026.

The recalled units were distributed worldwide, including in the United States in Florida, the District of Columbia, Georgia, Illinois, Indiana, Maryland, Michigan, North Carolina, Texas, Washington, and Wisconsin, and in Australia, Hong Kong, Israel, Japan, and Norway. The FDA classified the recall on March 19, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI matches.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. 0998-00-0802

    UDI-DI
    • 10607567111964

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution in the states of Florida, District of Columbia, Georgia, Illinois, Indiana, Maryland, Michigan, North Carolina, Texas, Washington, Wisconsin and the countries of Australia, Hong Kong, Israel, Japan, Norway.

Company
Datascope Corp.Mahwah, New Jersey
Risk

Low risk

Using it is unlikely to cause health problems.

FDA Class III recall · How risk is rated

Event ID
98432
Recall number
Z-1587-2026
Quantity recalled
28 units (20 US, 8 OUS)

All recalls from Datascope Corp.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)